Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The conference’s opening keynote sets the scene for 2025 and the years to come. 

Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds

The latest news for pharma industry insiders.

Pharma Pulse 10/15/24: Today’s Playbook for Startups, Key End Points in Clinical Trials & more

Videos

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses examples of how effective communication can resolve supply chain issues. 

Effective Resolutions to Supply Chain Issues

The company’s annual edition reveals the latest numbers in the sector, including a rise in average employer-sponsored health insurance premiums for single and family coverage of 24% and 28% respectively. 

KFF Releases Results of Employer Health Benefits Survey

Pharma Pulse 10/14/24: Trading Quality for Convenience? Specialists Not High on Improving Medicinal Cannabis Access

Given the magnitude of LogiPharma USA for the pharma logistics industry, what were some of the biggest themes that came out of the conference?

Three Themes Powering LogiPharma USA

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses how to handle opposing concerns between supply chain teams and offers communication solutions. 

LogiPharma USA 2024: Confronting Conflicting Priorities Between Supply Chain Partners

The now-11-year odyssey to track drugs by item through the supply chain will be under a regulatory exemption for up to two years.

Facing Potential Drug Shortages, FDA Delays Enforcement of DSCSA Compliance Deadline, with Stipulations

Pharma Pulse 10/11/24: Leverage AI to Lower Cost, Barriers to Cell Therapies & more

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead